Biotransformation of cyclosporin in primary rat, porcine and human liver cell co-cultures

References

• Bader A, Knop E, Boker KH, Crome O, Fruehauf N, Gonschior AK, Christians U, Esselmann H, Pichlmayr R, Sewing KF. Tacrolimus (FK 506) biotransformation in primary rat hepatocytes depends on extracellular matrix geometry. Naunyn Schmiedebergs Archives in Pharmacology 1996; 353: 461–473
   PubMedGoogle Scholar
• Bader A, Knop E, Fruhauf N, Crome O, Boker K, Christians U, Oldhafer K, Ringe B, Pichlmayr R, Sewing KF. Reconstruction of liver tissue in vitro: Geometry of characteristic flat bed, hollow fiber, and spouted bed bioreactors with reference to the in vivo liver. Artificial Organs 1995; 19: 941–950
   PubMed Web of Science ®Google Scholar
• Bader A, Rinkes IH, Closs EI, Ryan CM, Toner M, Cunningham JM, Tompkins RG, Yarmush ML. A stable long-term hepatocyte culture system for studies of physiologic processes: Cytokine stimulation of the acute phase response in rat and human hepatocytes. Biotechnology Progress 1992; 8: 219–225
   PubMed Web of Science ®Google Scholar
• Bader A, Zech K, Crome O, Christians U, Ringe B, Pichlmayr R, Sewing KF. Use of organotypical cultures of primary hepatocytes to analyse drug biotransformation in man and animals. Xenobiotica 1994; 24: 623–633
   PubMed Web of Science ®Google Scholar
• Behnia K, Bhatia S, Jastromb N, Balis U, Sullivan S, Yarmush M, Toner M. Xenobiotic metabolism by cultured primary porcine hepatocytes. Tissue Engineering 2000; 6: 467–479
   PubMedGoogle Scholar
• Bleck JS, Schlitt HJ, Christians U, Schottman R, Thiesemann C, Strohmeyer S, Kohlhaw K, Wonigeit K, Pichlmayr R, Sewing K-F. Ciclosporin metabolite pattern in blood and urine of kidney graft patients in relation to liver function. European Journal of Clinical Pharmacology 1991; 40: 565–569
   PubMedGoogle Scholar
• Bleck JS, Schlitt HJ, Christians U, Thiesemann C, Strohmeyer S, Schottman R, Kohlhaw K, Wonigeit K, Sewing K-F. Urinary excretion of Ciclosporin and 17 of its metabolites in renal allograft recipients. Pharmacology 1989; 39: 160–164
   PubMedGoogle Scholar
• Borel JF. Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity. Immunology 1976; 31: 631–641
   PubMed Web of Science ®Google Scholar
• Bouis P, Brouillard J-F, Fischer V, Donatsch P, Boelsterli UA. Effect of enzyme induction on SandimmunR (cyclosporin A) biotransformation and hepatotoxicity in cultured rat hepatocytes and in vivo. Biochemistry and Pharmacology 1990; 39: 257–266
   PubMed Web of Science ®Google Scholar
• Bowers LD, Canafax DM, Singh J, Seifedlin R, Simmons RL, Najarian JS. Studies of Cyclosporin blood levels: Analysis, clinical utility, pharmacokinetics, metabolites, and chronopharmacology. Transplant Proceedings 1986; 18: 137–143
   PubMed Web of Science ®Google Scholar
• Bueding E, Hawkins J, Cha Y. Antischistosomal effects of cyclosporin A. Agents Actions 1981; 11: 380–383
   PubMedGoogle Scholar
• Christians U, Braun F, Sattler M, Almeidal VMF, Linck A, Sewing K-F. Interactions of FK 506 and Cyclosporin metabolism. Transplant Proceedings 1991; 23: 2794–2796
   PubMedGoogle Scholar
• Christians U, Schlitt HJ, Bleck JS, Schiebel HM, Kownatzki R, Maurer G, Strohmeyer SS. Measurement of cyclosporine and 18 metabolites in blood, bile and urine by high performance liquid chromatography. Transplant Proceedings 1988; 20: 609–613
   PubMedGoogle Scholar
• Christians U, Sewing KF. Whole blood sample clean-up for chromatographic analysis. Selective sample handling and detection in high-performance liquid chromatography (Part B), K Zech, RW Frei. Elsevier, London 1989; 82–132
   Google Scholar
• Christians U, Sewing KF. Alternative cyclosporine metabolite pathways and toxicity. Clinical Biochemistry 1995; 28: 547–559
   PubMed Web of Science ®Google Scholar
• Christians U, Spiekermann K, Bader A, Schottmann R, Linck A, Wonigeit K, Sewing KF, Link H. Cyclosporin metabolite pattern in blood from patients with acute GVHD after BMT. Bone Marrow Transplant 1993; 12: 27–33
   PubMedGoogle Scholar
• Christians U, Zimmer KO, Wonigeit K, Sewing KF. Measurement of cyclosporin A and four metabolites in whole blood by high-performance liquid chromatography. Journal of Chromatography 1987; 413: 121–129
   PubMed Web of Science ®Google Scholar
• DiPersio CM, Jackson DA, Zaret KS. The extracellular matrix coordinately modulates liver transcription factors and hepatocyte morphology. Molecular Cell Biology 1991; 11: 4405–4414
   PubMedGoogle Scholar
• Dreyfuss M, Harri E, Hofmann H, Kobel H, Pache W, Tscherter H. Cyclosporin A and C. New metabolites from Trichoderma polysporum (Link ex Pers.) Rifai. European Journal of Applied Microbiology 1976; 3: 125–133
   Web of Science ®Google Scholar
• Dunn JC, Yarmush ML, Koebe HG, Tompkins RG. Hepatocyte function and extracellular matrix geometry: Long-term culture in a sandwich configuration. FASEB Journal 1989; 3: 174–177
   PubMed Web of Science ®Google Scholar
• Dunn JCY, Tompkins RG, Yarmush ML. Long-term in vitro function of adult hepatocytes in a collagen gel sandwich configuration. Biotechnology Progress 1991; 7: 237–245
   PubMed Web of Science ®Google Scholar
• Elsdale T, Bard J. Collagen substrata for studies on cell behavior. Journal of Cell Biology 1972; 54: 626–637
   PubMed Web of Science ®Google Scholar
• Ferrini J-B, Pichard L, Domergue J, Maurel P. Long-term primary cultures of adult human hepatocytes. Chemico-Biological Interactions 1997; 107: 31–45
   PubMed Web of Science ®Google Scholar
• Gross-Steinmeyer K, Stapleton PL, Tracy JH, Bammler TK, Lehman T, Strom SC, Eaton DL. Influence of Matrigel-overlay on constitutive and inducible expression of nine genes encoding drug-metabolizing enzymes in primary human hepatocytes. Xenobiotica 2005; 35: 419–438
   PubMed Web of Science ®Google Scholar
• Hamilton GA, Jolley SL, Gilbert D, Coon DJ, Barros S, LeCluyse EL. Regulation of cell morphology and cytochrome P450 expression in human hepatocytes by extracellular matrix and cell–cell interactions. Cell Tissue Research 2001; 306: 85–99
   PubMed Web of Science ®Google Scholar
• Kahan BD. Drug therapy. Cyclosporine. New England Journal of Medicine 1989; 321: 1725–1738
   PubMed Web of Science ®Google Scholar
• Kahan BD. Consensus Document: Hawk's Cay Meeting on Therapeutic Drug Monitoring of Cyclosporine. Transplant Proceedings 1990; 22: 1357–1361
   PubMedGoogle Scholar
• Kelly P, Kahan BD. Review: Metabolism of immunosuppressant drugs. Current Drug Metabolism 2002; 3: 275–287
   PubMed Web of Science ®Google Scholar
• Knop E, Bader A, Boker K, Pichlmayr R, Sewing KF. Ultrastructural and functional differentiation of hepatocytes under long-term culture conditions. The Anatomical Record 1995; 242: 337–349
   PubMedGoogle Scholar
• Kronbach T, Fischer V, Meyer UA. Cyclosporin metabolism in human liver: Identification of a cytochrome P-450 gene family as the major cyclosporinmetabolizing enzyme explains interactions of cyclosporin with other drugs. Clinical Pharmacology Therapy 1988; 43: 630–635
   PubMed Web of Science ®Google Scholar
• LeCluyse E, Bullock P, Madan A, Carroll K, Parkinson A. Influence of extracellular matrix overlay and medium formulation on the induction of cytochrome P-450 2B enzymes in primary cultures of rat hepatocytes. Drug Metabolism and Disposition 1999; 27: 909–915
   PubMed Web of Science ®Google Scholar
• Lensmeyer GL, Wiebe DA, Carlson IH. Identification and analysis of nine metabolites of Cyclosporin in whole blood by liquid chromatography. 1: Purification of analytical standards and optimization of the assay. Clinical Chemistry 1987; 33: 1841–1850
   PubMedGoogle Scholar
• Lensmeyer GL, Wiebe DA, Carlson IH. Deposition of nine metabolites of cyclosporine in human tissues, bile, urine, and whole blood. Transplant Proceedings 1988; 20: 614–622
   PubMedGoogle Scholar
• Maurer G, Lemaire M. Biotransformation and distribution in blood of Cyclosporin and its metabolites. Transplant Proceedings 1986; 18: 25–34
   PubMed Web of Science ®Google Scholar
• Maurer G, Loosli HR, Schreier E, Keller B. Disposition of Cyclosporin in several animal species and man. I. Structural elucidication of its metabolites. Drug Metabolism and Disposition 1984; 12: 120–126
   PubMed Web of Science ®Google Scholar
• Nickell SP, Scheibel LW, Cole GA. Inhibition by cyclosporin A of rodent malaria in vivo and human malaria in vitro. Infections and Immunology 1982; 37: 1093–1100
   PubMedGoogle Scholar
• Pichard L, Domergue J, Fourtanier G, Koch P, Schran HF, Maurel P. Metabolism of the new immunosuppressor Cyclosporin G by human liver cytochromes P450. Biochemistry and Pharmacology 1996; 51: 591–598
   PubMed Web of Science ®Google Scholar
• Pichard L, Fabre I, Fabre G, Domergue J, Aubert BS, Mourad G, Maurel P. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metabolism and Disposition 1990; 18: 595–606
   PubMed Web of Science ®Google Scholar
• Rosano TG, Freed BM, Pell MA, Lempert N. Cyclosporin metabolites in human blood and renal tissue. Transplant Proceedings 1986; 18: 35–40
   PubMedGoogle Scholar
• Ryffel B, Donatsch P, Madorin M, Matter BE, Ruttimann G, Schon H, Stoll R, Wilson J. Toxicological evaluation of cyclosporin A. Archives in Toxicology 1983; 53: 107–141
   PubMed Web of Science ®Google Scholar
• Seglen PO. Preparation of isolated rat liver cells. Methods in Cell Biology 1976; 13: 29–83
   PubMedGoogle Scholar
• Sidhu JS, Farin FM, Omiecinski CJ. Influence of extracellular matrix overlay on phenobarbital-mediated induction of CYP2B1, 2B2, and 3A1 genes in primary adult rat hepatocyte culture. Arch Biochemistry and Biophysics 1993; 301: 103–113
   PubMed Web of Science ®Google Scholar
• Vickers AE, Fischer V, Connors S, Fisher RL, Baldeck JP, Maurer G, Brendel K. Cyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines. Drug Metabolism and Disposition 1992; 20: 802–809
   PubMed Web of Science ®Google Scholar
• Vine W, Bowers LD. Cyclosporine: Structure, pharmacokinetics, and therapeutic drug monitoring. Critical Reviews in Clinical Laboratory Sciences 1987; 25: 275–311
   PubMed Web of Science ®Google Scholar
• Wagner O, Schreier E, Heitz F, Maurer G. Tissue distribution, disposition, and metabolism of cyclosporine in rats. Drug Metabolism and Disposition 1987; 15: 377–383
   PubMed Web of Science ®Google Scholar
• Wiesner RH, Ludwig J, Lindor KD, Jorgensen RA, Baldus WP. A controlled trial of cyclosporin in the treatment of primary biliary cirrhosis. New England Journal of Medicine 1990; 20: 1419–1424
   Google Scholar